Promoter holding
64.27%
AP
Astrozen Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Astrozen Pharmaceuticals: trust score, financial health, credit view, compliance, directors, growth and distre…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Astrozen Pharmaceuticals — 360° Intelligence Report
Generated from MCA filings & public records59/100
Trust Score
Moderate
Astrozen Pharmaceuticals is assessed as Moderate with a Trust Score of 59/100. Astrozen Pharmaceuticals is an active private limited indian non-government company incorporated in 2015, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 14 Aug 2026 from the latest processed filings. Astrozen Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 2 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
Charges position: 1 open (10.00 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Uco Bank | 1 | 48.0 cr |
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2022 - filings overdue.
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| LALLAN JAMEEDAR SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KAUSHILYA BHARTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| INDRA JEET JHINKAN BHARTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 35
Growth signals & trust indicators
Operating for 11+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 38% in a year.
Negative net worth.
Statutory filings appear overdue.
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence58/100
Review suggested
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment40/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 10.00 Lakh already registered.
- Compliance record supports lending.
Investor view38/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 7 events11 Aug 2023
Director appointed
LALLAN JAMEEDAR SINGH (Director)
30 Sep 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
24 Nov 2020
Charge created
Uco Bank - 10.00 Lakh
09 Jun 2015
Incorporated
Registered with Roc Mumbai Ii
Director appointed
KAUSHILYA BHARTI (Director)
Director appointed
INDRA JEET JHINKAN BHARTI (Director)
10
Key Observations
Auto-generated from the data aboveCompliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
| Company | CIN | Location |
|---|---|---|
| Acid & Chemical Manufacturers Association | U24119WB1959NPL024271 | Kolkata, West Bengal, India |
| Activebio Pharmaceuticals Private Limited | U24233DL2014PTC272443 | New Delhi, Delhi, India |
| Aphrasia Life Care Private Limited | U33111UP2007PTC033873 | Sader, Uttar Pradesh, India |
| Mast Hospitality Services Private Limited | U74900DL2009PTC195423 | Delhi, Delhi, India |
| Unishine Formulation Private Limited | U74110GJ2011PTC066729 | Rajkot, Gujarat, India |
| G R Chemicals Industry Private Limited | U74110MH1977PTC019927 | Thane, Maharashtra, India |
| All-Tech Chemical Trading Engineering Private Limited | U51496MH2004PTC150128 | Mumbai, Maharashtra, India |
| Mrs Products Pvt. Ltd. | U21029WB1995PTC068348 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Astrozen Pharmaceuticals before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Astrozen Pharmaceuticals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Astrozen Pharmaceuticals - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Astrozen Pharmaceuticals pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Astrozen Pharmaceuticals - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Astrozen Pharmaceuticals an active company?
Astrozen Pharmaceuticals has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Astrozen Pharmaceuticals financially healthy?
Astrozen Pharmaceuticals has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Astrozen Pharmaceuticals?
Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Astrozen Pharmaceuticals?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Astrozen Pharmaceuticals have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Astrozen Pharmaceuticals up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Astrozen Pharmaceuticals?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
